Position in WVE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,125,205
-$89,373 QoQ
Shares Held
193,667
+15.6% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 237 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. WVE ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in WVE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,125,205 | 193,667 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,214,578 | 167,528 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,412,215 | 141,895 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,165,146 | 159,173 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,056,893 | 162,599 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,072,216 | 132,700 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,544,270 | 124,840 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $881,696 | 107,524 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $627,911 | 125,834 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $751,148 | 121,742 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $578,704 | 114,595 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $641,188 | 111,511 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $383,965 | 105,485 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $80,498 | 40,249 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $118,324 | 37,683 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $181,545 | 37,050 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $228,970 | 34,380 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $171,189 | 30,515 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $243,025 | 30,880 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $218,405 | 25,725 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $296,060 | 28,440 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $284,398 | 30,352 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||